CA2469370C - Adipose-derived cell processing unit - Google Patents
Adipose-derived cell processing unit Download PDFInfo
- Publication number
- CA2469370C CA2469370C CA2469370A CA2469370A CA2469370C CA 2469370 C CA2469370 C CA 2469370C CA 2469370 A CA2469370 A CA 2469370A CA 2469370 A CA2469370 A CA 2469370A CA 2469370 C CA2469370 C CA 2469370C
- Authority
- CA
- Canada
- Prior art keywords
- cell
- cells
- tissue
- collection container
- processing unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012545 processing Methods 0.000 title claims abstract description 70
- 210000004027 cell Anatomy 0.000 claims abstract description 354
- 210000001519 tissue Anatomy 0.000 claims abstract description 229
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 166
- 210000000130 stem cell Anatomy 0.000 claims abstract description 126
- 238000002156 mixing Methods 0.000 claims description 45
- 239000000463 material Substances 0.000 claims description 37
- 239000000654 additive Substances 0.000 claims description 26
- 238000005406 washing Methods 0.000 claims description 22
- 230000000996 additive effect Effects 0.000 claims description 15
- 238000007443 liposuction Methods 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 10
- 239000004033 plastic Substances 0.000 claims description 9
- 229920003023 plastic Polymers 0.000 claims description 9
- 238000009987 spinning Methods 0.000 claims description 9
- 150000002632 lipids Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 abstract description 81
- 239000000203 mixture Substances 0.000 abstract description 34
- 108060005980 Collagenase Proteins 0.000 description 24
- 102000029816 Collagenase Human genes 0.000 description 24
- 210000001789 adipocyte Anatomy 0.000 description 22
- 210000001185 bone marrow Anatomy 0.000 description 21
- 229960002424 collagenase Drugs 0.000 description 21
- 239000012634 fragment Substances 0.000 description 20
- 238000000926 separation method Methods 0.000 description 20
- 230000003511 endothelial effect Effects 0.000 description 19
- 238000013459 approach Methods 0.000 description 17
- 239000012530 fluid Substances 0.000 description 17
- 239000002243 precursor Substances 0.000 description 17
- 230000007246 mechanism Effects 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 15
- 238000003306 harvesting Methods 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000002699 waste material Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 230000008901 benefit Effects 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 230000001404 mediated effect Effects 0.000 description 10
- 230000001172 regenerating effect Effects 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000007943 implant Substances 0.000 description 9
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000003102 growth factor Substances 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 239000007790 solid phase Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000906034 Orthops Species 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000002808 connective tissue Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 238000011109 contamination Methods 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000001671 embryonic stem cell Anatomy 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000028782 Hereditary disease Diseases 0.000 description 5
- 238000002617 apheresis Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000024245 cell differentiation Effects 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- 241001529936 Murinae Species 0.000 description 4
- 206010031243 Osteogenesis imperfecta Diseases 0.000 description 4
- 210000004504 adult stem cell Anatomy 0.000 description 4
- 210000003850 cellular structure Anatomy 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000001415 gene therapy Methods 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028851 Necrosis Diseases 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000013479 data entry Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000000432 density-gradient centrifugation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 239000012997 ficoll-paque Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000005188 flotation Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- 229940125721 immunosuppressive agent Drugs 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000002894 multi-fate stem cell Anatomy 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 210000004967 non-hematopoietic stem cell Anatomy 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 238000012384 transportation and delivery Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000702421 Dependoparvovirus Species 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000251206 Scyliorhinus canicula Species 0.000 description 2
- 241000251778 Squalus acanthias Species 0.000 description 2
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000439 acute liver injury Toxicity 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 239000003462 bioceramic Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 238000010322 bone marrow transplantation Methods 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- -1 demineralized bone Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001476 gene delivery Methods 0.000 description 2
- 238000002695 general anesthesia Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000002962 histologic effect Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 238000007898 magnetic cell sorting Methods 0.000 description 2
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 201000006938 muscular dystrophy Diseases 0.000 description 2
- 210000000066 myeloid cell Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000009818 osteogenic differentiation Effects 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- WNWVKZTYMQWFHE-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound [CH2]CN1CCOCC1 WNWVKZTYMQWFHE-UHFFFAOYSA-N 0.000 description 1
- 241000816129 Alcha Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 230000020955 B cell costimulation Effects 0.000 description 1
- 208000003950 B-cell lymphoma Diseases 0.000 description 1
- 208000028564 B-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000014015 Growth Differentiation Factors Human genes 0.000 description 1
- 108010050777 Growth Differentiation Factors Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 101150008942 J gene Proteins 0.000 description 1
- 108010052014 Liberase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000020385 T cell costimulation Effects 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 208000037919 acquired disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000001494 anti-thymocyte effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 238000007681 bariatric surgery Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000015624 blood vessel development Effects 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000003320 cell separation method Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000010231 histologic analysis Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 230000003189 isokinetic effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 1
- 229950007856 mofetil Drugs 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000004070 myogenic differentiation Effects 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 201000010459 osteogenesis imperfecta type 3 Diseases 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000822 sequential centrifugation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 208000013363 skeletal muscle disease Diseases 0.000 description 1
- 210000004683 skeletal myoblast Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013337 sub-cultivation Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000011296 tyrosinemia Diseases 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/76—Handpieces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0283—Pointed or sharp biopsy instruments with vacuum aspiration, e.g. caused by retractable plunger or by connected syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/08—Lipoids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1384—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2849201A CA2849201A1 (en) | 2001-12-07 | 2002-12-09 | Adipose-derived cell processing unit |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33885601P | 2001-12-07 | 2001-12-07 | |
| US60/338,856 | 2001-12-07 | ||
| PCT/US2002/039465 WO2003053346A2 (en) | 2001-12-07 | 2002-12-09 | Systems and methods for treating patients with processed lipoaspirate cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2849201A Division CA2849201A1 (en) | 2001-12-07 | 2002-12-09 | Adipose-derived cell processing unit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2469370A1 CA2469370A1 (en) | 2003-07-03 |
| CA2469370C true CA2469370C (en) | 2014-07-08 |
Family
ID=23326433
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2469370A Expired - Fee Related CA2469370C (en) | 2001-12-07 | 2002-12-09 | Adipose-derived cell processing unit |
| CA2849201A Abandoned CA2849201A1 (en) | 2001-12-07 | 2002-12-09 | Adipose-derived cell processing unit |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2849201A Abandoned CA2849201A1 (en) | 2001-12-07 | 2002-12-09 | Adipose-derived cell processing unit |
Country Status (11)
| Country | Link |
|---|---|
| US (12) | US20030161816A1 (https=) |
| EP (4) | EP2305276A3 (https=) |
| JP (4) | JP4653952B2 (https=) |
| KR (5) | KR20120003961A (https=) |
| CN (2) | CN101897724B (https=) |
| AU (1) | AU2002357135C1 (https=) |
| BR (1) | BR0214772A (https=) |
| CA (2) | CA2469370C (https=) |
| DK (1) | DK1921133T3 (https=) |
| ES (1) | ES2545385T3 (https=) |
| WO (1) | WO2003053346A2 (https=) |
Families Citing this family (371)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050048036A1 (en) * | 2001-12-07 | 2005-03-03 | Hedrick Marc H. | Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues |
| US7514075B2 (en) * | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
| US20060204556A1 (en) * | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
| US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US7595043B2 (en) * | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| JP4653952B2 (ja) | 2001-12-07 | 2011-03-16 | サイトリ セラピューティクス インコーポレイテッド | 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法 |
| US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
| US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
| AU2003220424A1 (en) * | 2002-03-19 | 2003-10-08 | Advanced Research And Technology Transfer | Adipose stromal stem cells for tissue and vascular modification |
| US9144583B2 (en) | 2002-03-29 | 2015-09-29 | Tissue Genesis, Inc. | Cell separation apparatus and methods of use |
| US8202725B2 (en) | 2004-12-23 | 2012-06-19 | Tissue Genesis Incorporated | Cell sodding method and apparatus |
| US7992725B2 (en) * | 2002-05-03 | 2011-08-09 | Biomet Biologics, Llc | Buoy suspension fractionation system |
| US7832566B2 (en) | 2002-05-24 | 2010-11-16 | Biomet Biologics, Llc | Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles |
| US20030205538A1 (en) | 2002-05-03 | 2003-11-06 | Randel Dorian | Methods and apparatus for isolating platelets from blood |
| US20060278588A1 (en) | 2002-05-24 | 2006-12-14 | Woodell-May Jennifer E | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7845499B2 (en) | 2002-05-24 | 2010-12-07 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| DE10392686T5 (de) | 2002-05-24 | 2005-07-07 | Biomet Mfg. Corp., Warsaw | Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten |
| US7160719B2 (en) * | 2002-06-07 | 2007-01-09 | Mayo Foundation For Medical Education And Research | Bioartificial liver system |
| CA2516510C (en) * | 2003-02-20 | 2012-07-10 | Macropore Biosurgery, Inc. | Method of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
| AU2004260638A1 (en) * | 2003-06-18 | 2005-02-10 | Macropore Biosurgery Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US20050026275A1 (en) * | 2003-06-23 | 2005-02-03 | Andrej Bahoric | Device, system and method for receiving, processing and dispersing cells |
| KR101127305B1 (ko) | 2003-06-25 | 2012-04-23 | 사이토리 테라퓨틱스, 인크. | 조직으로부터 재생성 세포를 분리하고 농축시키기 위한시스템 및 방법 |
| US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
| US7172579B2 (en) * | 2003-09-09 | 2007-02-06 | Civco Medical Instruments Co., Inc. | System and method for irrigation and tissue evacuation and collection |
| CA2539346A1 (en) * | 2003-09-17 | 2005-04-21 | Macropore Biosurgery, Inc. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| US9074190B2 (en) * | 2003-10-07 | 2015-07-07 | Biomaster, Inc. | Cell differentiation of adipose-derived precursor cells |
| JP2007508018A (ja) | 2003-10-08 | 2007-04-05 | べト−ステム インコーポレイテッド | 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット |
| EP1743021B1 (en) * | 2004-03-19 | 2014-03-26 | Cytori Therapeutics, Inc. | Method of preparing regenerative cells on a cell carrier and cell carrier containment device |
| US7588732B2 (en) * | 2004-03-30 | 2009-09-15 | Genesis Biosystems, Inc. | Autologus tissue harvesting and irrigation device |
| WO2005108559A2 (en) * | 2004-04-23 | 2005-11-17 | Bioe, Inc. | Multi-lineage progenitor cells |
| CA3090413C (en) | 2004-06-04 | 2023-10-10 | Abbott Diabetes Care Inc. | Glucose monitoring and graphical representations in a data management system |
| WO2006014159A2 (en) * | 2004-07-01 | 2006-02-09 | Macropore Biosurgery Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| DK1778834T5 (da) * | 2004-07-01 | 2012-01-09 | Cytori Therapeutics Inc | Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser |
| CA2572113C (en) * | 2004-07-01 | 2017-04-18 | Macropore Biosurgery Inc. | Methods of using regenerative cells to promote wound healing |
| CN102204928B (zh) * | 2004-07-01 | 2014-09-17 | 马克罗珀尔生物外科公司 | 再生细胞用于促进伤口愈合的应用 |
| WO2006014158A1 (en) * | 2004-07-01 | 2006-02-09 | Macropore Biosurgery Inc. | Treating disorders by administering regenerative cells. |
| EP1765980A4 (en) * | 2004-07-02 | 2007-12-12 | Cytori Therapeutics Inc | SYSTEMS AND METHOD FOR THE INSULATION AND USE OF CLINICALLY SAFE, FAT-GUN-GENERATING REGENERATIVE CELLS |
| US8715733B2 (en) | 2004-07-23 | 2014-05-06 | DePuy Synthes Products, LLC | Enhanced adipose tissue |
| US7993578B2 (en) * | 2004-10-29 | 2011-08-09 | Depuy Spine, Inc. | Methods and kits for aseptic filling of products |
| US20060134781A1 (en) * | 2004-12-07 | 2006-06-22 | Bacterin International, Inc. | Three-dimensional cell culture system |
| US8017395B2 (en) * | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| EP1830862B1 (en) * | 2004-12-30 | 2012-12-19 | PrimeGen Biotech LLC | Adipose-derived stem cells for tissue regeneration and wound healing |
| JP5138384B2 (ja) * | 2005-01-10 | 2013-02-06 | サイトリ セラピューティクス インコーポレイテッド | 医療装置を監視し、管理し、サービスするための装置及び方法 |
| US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| WO2006086201A2 (en) | 2005-02-07 | 2006-08-17 | Hanuman Llc | Platelet rich plasma concentrate apparatus and method |
| WO2006086199A1 (en) | 2005-02-07 | 2006-08-17 | Hanuman Llc | Platelet rich plasma concentrate apparatus and method |
| US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US8062286B2 (en) * | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
| US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
| US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
| KR100907248B1 (ko) * | 2005-04-21 | 2009-07-10 | (주)안트로젠 | 분화된 어린 지방 세포와 생분해성 중합체의 이식에 의한신체의 부피 대체 방법 |
| KR101278437B1 (ko) * | 2005-05-25 | 2013-06-25 | 사이토리 테라퓨틱스, 인크. | 심혈관 증상의 치료에 지방조직-유래의 세포를 사용하는방법 |
| AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| CA2613889A1 (en) * | 2005-06-08 | 2006-12-14 | Centocor, Inc. | A cellular therapy for ocular degeneration |
| JP4907908B2 (ja) * | 2005-06-29 | 2012-04-04 | ルネサスエレクトロニクス株式会社 | 駆動回路及び表示装置 |
| CA2615208A1 (en) * | 2005-07-12 | 2007-01-18 | Tissue Genesis, Inc. | Apparatus and methods for preparing tissue grafts |
| US7531355B2 (en) * | 2005-07-29 | 2009-05-12 | The Regents Of The University Of California | Methods and compositions for smooth muscle reconstruction |
| FR2890976B1 (fr) | 2005-09-20 | 2007-12-14 | Univ La Reunion | Kit pour preparer une composition comprenant des cellules adipocytaires et procede d'obtention de ladite composition |
| KR20070095494A (ko) * | 2005-09-28 | 2007-10-01 | 세원셀론텍(주) | 지방 조직 수복용 반고형성 젤 조성물의 제조방법 |
| WO2007044418A2 (en) * | 2005-10-06 | 2007-04-19 | Moscatello David K | Cell culture media, kits and methods of use |
| WO2007046501A1 (ja) | 2005-10-21 | 2007-04-26 | Kaneka Corporation | 幹細胞の分離材および分離方法 |
| US20070213718A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
| US20070227547A1 (en) * | 2006-02-14 | 2007-10-04 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
| US20070213717A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Biological fusion in the vertebral column |
| US8163018B2 (en) | 2006-02-14 | 2012-04-24 | Warsaw Orthopedic, Inc. | Treatment of the vertebral column |
| US8016859B2 (en) | 2006-02-17 | 2011-09-13 | Medtronic, Inc. | Dynamic treatment system and method of use |
| KR100764640B1 (ko) * | 2006-03-08 | 2007-10-10 | 세원셀론텍(주) | 지방조직 수복용 키트 |
| US20070224173A1 (en) * | 2006-03-21 | 2007-09-27 | Koullick Edouard A | Nonexpansion Protocol for Autologous Cell-Based Therapies |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| US20070258956A1 (en) * | 2006-05-02 | 2007-11-08 | Biomet Manufacturing Corp. | Methods and apparatus for promoting hair growth using adipose cell based therapies |
| US8567609B2 (en) | 2006-05-25 | 2013-10-29 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US20090304644A1 (en) * | 2006-05-30 | 2009-12-10 | Cytori Therapeutics, Inc. | Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue |
| WO2007145442A1 (en) * | 2006-06-14 | 2007-12-21 | Infitron, Inc. | Composition for transplantation comprising adipose stem cells or adipocytes |
| JP2009539546A (ja) * | 2006-06-15 | 2009-11-19 | アールエヌエル バイオ カンパニー，リミティッド | ヒト脂肪組織由来成体幹細胞、繊維芽細胞、及び脂肪又は脂肪細胞を含有する皮膚美容又は形成用の組成物 |
| US20100015104A1 (en) * | 2006-07-26 | 2010-01-21 | Cytori Therapeutics, Inc | Generation of adipose tissue and adipocytes |
| US20100092432A1 (en) * | 2006-08-08 | 2010-04-15 | Takenori Ozaki | Cell preparation containing multipotential stem cells originating in fat tissue |
| CA2661935C (en) * | 2006-08-29 | 2013-07-09 | Tissue Genesis, Inc. | Catheter for cell delivery |
| EP1897570A1 (en) * | 2006-09-08 | 2008-03-12 | Gelanus B.V. | Blood recuperation device and method |
| DE602007004546D1 (de) | 2006-09-28 | 2010-03-18 | Tyco Healthcare | Tragbares Wundtherapiesystem |
| US8968272B2 (en) * | 2006-10-06 | 2015-03-03 | Lipocosm Llc | Closed system and method for atraumatic, low pressure, continuous harvesting, processing, and grafting of lipoaspirate |
| US8241198B2 (en) * | 2006-11-03 | 2012-08-14 | University Of Utah Foundation | Ventricular assist device capable of implantation of stem cells |
| US20130324882A1 (en) * | 2012-05-30 | 2013-12-05 | Devicor Medical Products, Inc. | Control for biopsy device |
| WO2008099696A1 (ja) * | 2007-02-16 | 2008-08-21 | Olympus Corporation | 脂肪消化終了判定装置および脂肪組織消化装置 |
| US8034014B2 (en) | 2007-03-06 | 2011-10-11 | Biomet Biologics, Llc | Angiogenesis initation and growth |
| WO2008124494A1 (en) * | 2007-04-03 | 2008-10-16 | The Cleveland Clinic Foundation | Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material |
| WO2008127639A1 (en) | 2007-04-12 | 2008-10-23 | Biomet Biologics, Llc | Buoy suspension fractionation system |
| US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
| US11174458B2 (en) | 2007-04-23 | 2021-11-16 | Koligo Therapeutics, Inc. | Cell separation apparatus and methods of use |
| US8574567B2 (en) | 2007-05-03 | 2013-11-05 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
| US20100291042A1 (en) | 2007-05-03 | 2010-11-18 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
| DE602007010434D1 (de) * | 2007-06-01 | 2010-12-23 | Allergan Inc | Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| US9408954B2 (en) | 2007-07-02 | 2016-08-09 | Smith & Nephew Plc | Systems and methods for controlling operation of negative pressure wound therapy apparatus |
| GB0715259D0 (en) | 2007-08-06 | 2007-09-12 | Smith & Nephew | Canister status determination |
| GB0712763D0 (en) | 2007-07-02 | 2007-08-08 | Smith & Nephew | Apparatus |
| EP2192908A4 (en) * | 2007-07-25 | 2010-09-01 | Bioe Inc | DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES |
| CA3114827C (en) | 2007-07-31 | 2023-09-05 | Lifescan, Inc. | Differentiation of human embryonic stem cells to pancreatic endocrine |
| US12121648B2 (en) | 2007-08-06 | 2024-10-22 | Smith & Nephew Plc | Canister status determination |
| EP2229434B1 (en) | 2007-11-27 | 2011-09-07 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| WO2009073724A1 (en) | 2007-12-04 | 2009-06-11 | Ingeneron, Inc. | Apparatus and methods for cell isolation |
| US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
| US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
| US20090181104A1 (en) * | 2007-12-14 | 2009-07-16 | Gino Rigotti | Breast reconstruction or augmentation using computer-modeled deposition of processed adipose tissue |
| US20090192528A1 (en) * | 2008-01-29 | 2009-07-30 | Biomet Biologics, Inc. | Method and device for hernia repair |
| US20090209456A1 (en) * | 2008-02-19 | 2009-08-20 | Iliana Sweis | Compositions and methods for improving facial and body aesthetics |
| KR101731474B1 (ko) | 2008-02-21 | 2017-05-11 | 얀센 바이오테크 인코포레이티드 | 세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물 |
| EP2620139B1 (en) | 2008-02-27 | 2016-07-20 | Biomet Biologics, LLC | Interleukin-1 receptor antagonist rich solutions |
| GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
| WO2009111338A1 (en) * | 2008-02-29 | 2009-09-11 | Biomet Manufacturing Corp. | A system and process for separating a material |
| US8754056B2 (en) | 2008-03-20 | 2014-06-17 | University Of Florida Research Foundation, Inc. | Enhancing vessel lesion homing and repair potential of stem cells |
| AU2009228203B2 (en) * | 2008-03-26 | 2014-11-20 | Ams Research Corporation | Treatment of pelvic floor disorders with an adipose-derived cell composition |
| ES2654542T3 (es) * | 2008-04-30 | 2018-02-14 | Genomix Co., Ltd. | Procedimiento de recolección de células funcionales in vivo con alta eficiencia |
| US8414519B2 (en) | 2008-05-21 | 2013-04-09 | Covidien Lp | Wound therapy system with portable container apparatus |
| CA2724839A1 (en) * | 2008-05-21 | 2009-11-26 | Bioe Llc | Differentiation of multi-lineage progenitor cells to pancreatic cells |
| US10912869B2 (en) | 2008-05-21 | 2021-02-09 | Smith & Nephew, Inc. | Wound therapy system with related methods therefor |
| US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
| JP5015865B2 (ja) * | 2008-06-09 | 2012-08-29 | オリンパス株式会社 | 脂肪組織洗浄装置 |
| US9144584B2 (en) * | 2008-06-11 | 2015-09-29 | Cell4Vet Corporation | Adipose tissue-derived stem cells for veterinary use |
| PL2310492T3 (pl) | 2008-06-30 | 2015-12-31 | Janssen Biotech Inc | Różnocowanie pluripotencjalnych komórek macierzystych |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| WO2010019886A1 (en) * | 2008-08-14 | 2010-02-18 | Osiris Therapeutics, Inc. | Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| US8827983B2 (en) | 2008-08-21 | 2014-09-09 | Smith & Nephew, Inc. | Sensor with electrical contact protection for use in fluid collection canister and negative pressure wound therapy systems including same |
| AU2009201915C1 (en) | 2008-08-22 | 2015-02-26 | Regeneus Ltd | Therapeutic methods |
| AU2011247866C9 (en) * | 2008-08-22 | 2014-02-13 | Regeneus Ltd. | Allogeneic therapeutic methods using adipose tissue-derived cell suspensions |
| US8512695B2 (en) * | 2008-10-21 | 2013-08-20 | The General Hospital Corporation | Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188 |
| MX349178B (es) * | 2008-10-31 | 2017-07-17 | Centocor Ortho Biotech Inc | Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático. |
| PL2346988T3 (pl) | 2008-10-31 | 2017-10-31 | Janssen Biotech Inc | Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki |
| US20100112696A1 (en) * | 2008-11-03 | 2010-05-06 | Baxter International Inc. | Apparatus And Methods For Processing Tissue To Release Cells |
| US8865199B2 (en) * | 2008-11-17 | 2014-10-21 | Ingeneron, Inc. | Biomatrix composition and methods of biomatrix seeding |
| ES2642070T3 (es) | 2008-11-20 | 2017-11-15 | Janssen Biotech, Inc. | Cultivo de células madre pluripotentes en microportadores |
| ES2584053T3 (es) * | 2008-11-20 | 2016-09-23 | Janssen Biotech, Inc. | Métodos y composiciones para la unión de células y cultivo en sustratos planos |
| US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
| US8309343B2 (en) | 2008-12-01 | 2012-11-13 | Baxter International Inc. | Apparatus and method for processing biological material |
| JP2010178830A (ja) * | 2009-02-04 | 2010-08-19 | Olympus Corp | 生体移植材とその製造方法 |
| PL2408401T3 (pl) | 2009-03-03 | 2016-10-31 | Sposoby, urządzenia i układy dla inżynierii tkanki kostnej z wykorzystaniem bioreaktora | |
| US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
| WO2010105204A2 (en) | 2009-03-13 | 2010-09-16 | Mayo Foundation For Medical Education And Research | Bioartificial liver |
| US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| AU2009100401A4 (en) * | 2009-04-30 | 2009-06-04 | Gl Holdings Inc Bv | Method of extracting and activating adipose-derived stem cells |
| US8333740B2 (en) * | 2009-05-01 | 2012-12-18 | Shippert Ronald D | Tissue transfer cannula |
| KR101738324B1 (ko) | 2009-05-01 | 2017-05-19 | 비미니 테크놀로지스 엘엘씨 | 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물 |
| US8740383B2 (en) | 2009-05-06 | 2014-06-03 | University Of Virginia Patent Foundation | Self-illuminated handheld lens for retinal examination and photography and related method thereof |
| US20100291534A1 (en) * | 2009-05-12 | 2010-11-18 | National Central University | Methods and Systems for Isolating, Ex Vivo Expanding and Harvesting Hematopoietic Stem Cells |
| US8100874B1 (en) | 2009-05-22 | 2012-01-24 | Donnell Mark Jordan | Tissue refining device |
| US9867788B2 (en) * | 2009-07-09 | 2018-01-16 | Boston Scientific Scimed, Inc. | Multi-chamber cellular mixing and delivery system and method |
| US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
| KR102058901B1 (ko) | 2009-07-20 | 2019-12-24 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| EP2456859A4 (en) | 2009-07-20 | 2015-03-18 | Janssen Biotech Inc | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS |
| SG177483A1 (en) * | 2009-07-20 | 2012-02-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
| US20110213336A1 (en) | 2009-08-05 | 2011-09-01 | Cucin Robert L | Method of and apparatus for sampling, processing and collecting tissue and reinjecting the same into human patients |
| US8348929B2 (en) | 2009-08-05 | 2013-01-08 | Rocin Laboratories, Inc. | Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient |
| US8465471B2 (en) * | 2009-08-05 | 2013-06-18 | Rocin Laboratories, Inc. | Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient |
| US8784803B2 (en) * | 2009-08-28 | 2014-07-22 | Osaka Air Machine Service, Ltd. | Therapeutic agent for liver-related diseases |
| WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
| US20110086426A1 (en) * | 2009-10-13 | 2011-04-14 | Lipostem Corp. | Methods and apparatus for collecting and separating regenerative cells from adipose tissue |
| US11191786B2 (en) | 2009-10-28 | 2021-12-07 | StemRIM Inc. | Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood |
| CN102058905B (zh) * | 2009-11-18 | 2013-04-24 | 四川大学 | 一种复合脂肪颗粒及其制备方法 |
| US20140286911A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
| WO2011075700A1 (en) * | 2009-12-18 | 2011-06-23 | Birsect, Llc. | Adipose tissue management systems |
| SE0951009A1 (sv) | 2009-12-22 | 2011-06-23 | Anordning och förfarande för rening och anrikning av biologiskt prov | |
| SG181687A1 (en) | 2009-12-23 | 2012-07-30 | Centocor Ortho Biotech Inc | Differentiation of human embryonic stem cells |
| CA2784425A1 (en) | 2009-12-23 | 2011-06-30 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
| AT509071B1 (de) * | 2010-01-29 | 2011-06-15 | Heinrich Karl Georg Ddr | Verfahren zur reinigung mesenchymaler stammzellen |
| US10588609B2 (en) * | 2010-02-04 | 2020-03-17 | Procept Biorobotics Corporation | Gene analysis and generation of stem cell methods and apparatus |
| EP2542667A4 (en) | 2010-03-01 | 2013-07-31 | Janssen Biotech Inc | PROCESS FOR CLEANING CELLS OBTAINED FROM PLURIPOTENTIAL STEM CELLS |
| ITGE20100026A1 (it) * | 2010-03-23 | 2011-09-24 | Carlo Tremolada | Metodo e dispositivo per la preparazione di tessuto, in particolare tessuto adiposo per trapianto ottenuto da materiale adiposo lobulare estratto tramite liposuzione |
| US8591391B2 (en) | 2010-04-12 | 2013-11-26 | Biomet Biologics, Llc | Method and apparatus for separating a material |
| US8790321B2 (en) | 2010-04-21 | 2014-07-29 | Genesis Medical Devices, LLC | Apparatus, system, and method for harvesting improved bone graft material with reamer-irrigator-aspirator (RIA) device |
| RU2663339C1 (ru) | 2010-05-12 | 2018-08-03 | Янссен Байотек, Инк. | Дифференцирование эмбриональных стволовых клеток человека |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9206387B2 (en) | 2010-07-09 | 2015-12-08 | The Gid Group, Inc. | Method and apparatus for processing adipose tissue |
| US9296984B2 (en) | 2010-07-09 | 2016-03-29 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
| US9260697B2 (en) | 2010-07-09 | 2016-02-16 | The Gid Group, Inc. | Apparatus and methods relating to collecting and processing human biological material containing adipose |
| WO2013106655A1 (en) | 2012-01-11 | 2013-07-18 | The Gid Group, Inc. | Method for processing adipose tissue and processing apparatus |
| US9669200B2 (en) | 2010-08-06 | 2017-06-06 | Boston Scientific Scimed, Inc. | Systems and methods for the treatment of pelvic disorders including magnetic particulates |
| WO2012019103A2 (en) | 2010-08-06 | 2012-02-09 | The General Hospital Corporation D/B/A | System and apparatus for cell treatment |
| CN103221536B (zh) | 2010-08-31 | 2016-08-31 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| EP2611907B1 (en) | 2010-08-31 | 2016-05-04 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| ES2658146T3 (es) | 2010-08-31 | 2018-03-08 | Janssen Biotech, Inc. | Diferenciación de células madre embrionarias humanas |
| WO2012047286A1 (en) * | 2010-10-04 | 2012-04-12 | Spinesmith Partners L.P. | Device and method for delivering mechanically released cells from liposuction aspirates |
| US20120087933A1 (en) | 2010-10-08 | 2012-04-12 | Samson Tom | Enhanced msc preparations |
| WO2012068248A2 (en) * | 2010-11-16 | 2012-05-24 | Ingeneron, Inc. | Methods for preserving target cells |
| US9180172B2 (en) | 2010-12-15 | 2015-11-10 | Ams Research Corporation | Treatment of Peyronies disease |
| US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| NZ612801A (en) | 2010-12-27 | 2014-12-24 | Intellicell Biosciences Inc | Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
| CN102151153A (zh) * | 2011-03-25 | 2011-08-17 | 吴成翰 | 外科手术过程中组织碎片的回收装置 |
| US8512326B2 (en) | 2011-06-24 | 2013-08-20 | Arqos Surgical, Inc. | Tissue extraction devices and methods |
| EP2703487B1 (en) | 2011-04-26 | 2018-06-27 | Genomix Co., Ltd. | Peptide for inducing regeneration of tissue and use thereof |
| US10035118B2 (en) * | 2011-04-28 | 2018-07-31 | Spinesmith Partners, L.P. | Lipoaspirate stem cell separation system and methods thereof |
| US9109198B2 (en) | 2011-04-29 | 2015-08-18 | General Electric Company | Automated systems and methods for isolating regenerative cells from adipose tissue |
| US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
| AR087159A1 (es) | 2011-06-20 | 2014-02-26 | Gen Biscuit | Galletita para desayuno con glucosa de lenta disponibilidad |
| WO2012178119A2 (en) | 2011-06-24 | 2012-12-27 | Arqos Surgical, Inc. | Tissue extraction devices and methods |
| US9233193B2 (en) | 2011-06-29 | 2016-01-12 | Iogyn, Inc. | Surgical fluid management systems and methods |
| US8582527B2 (en) * | 2011-07-01 | 2013-11-12 | Ofinno Technologies, Llc | Hybrid automatic repeat request in multicarrier systems |
| EP2564611B1 (en) | 2011-07-01 | 2015-02-18 | Ofinno Technologies, LLC | Synchronization signal and control messages in multicarrier OFDM |
| US8369280B2 (en) | 2011-07-01 | 2013-02-05 | Ofinno Techologies, LLC | Control channels in multicarrier OFDM transmission |
| US9737362B2 (en) | 2011-07-06 | 2017-08-22 | Boston Scientific Scimed, Inc. | Tissue cutting systems and methods |
| US11766459B2 (en) | 2011-07-08 | 2023-09-26 | Jointechlabs, Inc. | System and methods for preparation of adipose-derived stem cells |
| US9931445B2 (en) * | 2011-07-08 | 2018-04-03 | Jointechlabs, Inc. | System and methods for preparation of adipose-derived stem cells |
| US12239669B2 (en) | 2011-07-08 | 2025-03-04 | Jointechlabs, Inc. | System and methods for preparation of adipose-derived stem cells |
| US10967110B2 (en) | 2011-07-08 | 2021-04-06 | Jointechlabs, Inc. | System and methods for preparation of adipose-derived stem cells |
| US20150004702A1 (en) * | 2011-08-29 | 2015-01-01 | Stempeutics Research Private Limited | System for isolating stromal vascular fraction (svf) cells from the adipose tissue and a method thereof |
| US9084847B2 (en) * | 2011-09-22 | 2015-07-21 | Iogyn, Inc. | Surgical fluid management systems and methods |
| DK2744892T3 (en) * | 2011-09-23 | 2019-04-23 | Cell Ideas Pty Ltd | THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS |
| US10154664B2 (en) | 2011-10-06 | 2018-12-18 | David K Moscatello | Systems and methods for the digestion of adipose tissue samples obtained from a client for cryopreservation |
| JP5628131B2 (ja) * | 2011-10-19 | 2014-11-19 | サイトリ セラピューティクス インコーポレイテッド | 心血管状態の治療において脂肪組織由来細胞を使用する方法 |
| US9597149B2 (en) | 2011-11-04 | 2017-03-21 | Iogyn, Inc. | Tissue extraction devices and methods |
| ES2725564T3 (es) | 2011-11-08 | 2019-09-24 | Auxocell Laboratories Inc | Sistemas y métodos de procesamiento celular |
| US8446844B1 (en) | 2011-12-04 | 2013-05-21 | Ofinno Technologies, Llc | Handover in multicarrier wireless networks |
| US9512405B2 (en) | 2011-12-14 | 2016-12-06 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Non-enzymatic method for isolating human adipose-derived stromal stem cells |
| KR102203056B1 (ko) | 2011-12-22 | 2021-01-14 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화 |
| US10751374B2 (en) | 2012-01-30 | 2020-08-25 | Michael P. Zahalsky | Methods and compositions for treatment of penile defects |
| US20180028575A1 (en) | 2012-01-30 | 2018-02-01 | Michael Zahalsky | Methods and compositions for treatment of penile defects |
| JP5572777B2 (ja) * | 2012-02-24 | 2014-08-13 | 正典 佐伯 | 脂肪細胞を含む細胞製剤 |
| HK1206058A1 (en) | 2012-03-07 | 2015-12-31 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| US9497756B2 (en) | 2012-03-25 | 2016-11-15 | Comcast Cable Communications, Llc | Base station radio resource management |
| MX359002B (es) | 2012-04-13 | 2018-09-12 | K Stemcell Co Ltd | Metodo y composicion para prevenir la interrupcion y agregacion de celulas madre. |
| US9949265B2 (en) | 2012-05-04 | 2018-04-17 | Comcast Cable Communications, Llc | Control channel in a wireless communication system |
| WO2013180952A1 (en) | 2012-05-30 | 2013-12-05 | Lifecell Corporation | Device for harvesting, processing, and transferring adipose tissue |
| AU2013271581B2 (en) | 2012-06-08 | 2018-08-09 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
| DE102013209718B4 (de) | 2012-06-22 | 2015-09-10 | Human Med Ag | Vorrichtung zum Separieren von adulten Stammzellen |
| ITGE20120084A1 (it) * | 2012-08-24 | 2014-02-25 | Carlo Tremolada | Derivato tissutale di origine non embrionale arricchito di elementi staminali e multipotenti e metodo di preparazione di un medicamento con tale derivato |
| US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| AU2013310961B2 (en) * | 2012-08-29 | 2015-04-02 | Euromi S.A. | Apparatus for extracting and re-injecting adipose tissue |
| BR112015004003B1 (pt) | 2012-09-06 | 2020-05-19 | The Gid Group, Inc. | aparelho para processar material biológico humano contendo tecido fibroso e método para processar tecido adiposo |
| US20140081237A1 (en) * | 2012-09-20 | 2014-03-20 | Tissue Genesis, Inc. | Hand-held micro-liposuction adipose harvester, processor, and cell concentrator |
| BR112014028068A2 (pt) | 2012-09-25 | 2017-08-08 | Stem Cell Partners Llc | método e aparelho para preparar soro de trombina de doador único |
| JP6062055B2 (ja) * | 2012-09-28 | 2017-01-18 | スイス・ステム・セル・ファンデーションＳｗｉｓｓ Ｓｔｅｍ Ｃｅｌｌ Ｆｏｕｎｄａｔｉｏｎ | 精製幹細胞分画を調製する安全性の高い方法 |
| US9498244B2 (en) | 2012-10-19 | 2016-11-22 | Iogyn, Inc. | Medical systems and methods |
| DK2913059T3 (en) | 2012-10-25 | 2018-06-25 | Genomix Co Ltd | Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT |
| AU2013335684B2 (en) | 2012-10-25 | 2017-06-29 | Osaka University | Novel method for treating cardiac infarction using HMGB1 fragment |
| US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
| KR102030028B1 (ko) * | 2012-11-12 | 2019-10-08 | 한스바이오메드 주식회사 | 지방 조직 농축 시스템 |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| BR112015015770A2 (pt) | 2012-12-31 | 2017-07-11 | Janssen Biotech Inc | cultivo de células-tronco embrionárias humanas na interface ar-líquido para diferenciação em células pancreáticas endócrinas |
| JP6557147B2 (ja) | 2012-12-31 | 2019-08-07 | ヤンセン バイオテツク，インコーポレーテツド | Ｈｂ９調節物を用いたヒト胚性幹細胞の膵臓内分泌細胞への分化 |
| RU2687379C2 (ru) | 2012-12-31 | 2019-05-13 | Янссен Байотек, Инк. | Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки |
| US9775864B2 (en) | 2013-01-31 | 2017-10-03 | Ams Research Corporation | Vaginal laxity therapy utilizing cell-based bulking compositions |
| US9650608B2 (en) | 2013-02-22 | 2017-05-16 | Medivet America, Llc | Activating adipose-derived stem cells for transplantation |
| US9867939B2 (en) | 2013-03-12 | 2018-01-16 | Allergan, Inc. | Adipose tissue combinations, devices, and uses thereof |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| FR3003576B1 (fr) * | 2013-03-25 | 2017-09-01 | Michel Roche | Dispositif et procede de traitement de cellules graisseuses, notamment pour nettoyer et filtrer les cellules graisseuses d’un patient en vue d’un lipofilling |
| EP3375466B1 (en) | 2013-04-08 | 2020-05-13 | Boston Scientific Scimed, Inc. | Medical systems |
| US10124126B2 (en) * | 2013-04-18 | 2018-11-13 | The Regents Of The University Of Colorado, A Body Corporate | System and methods for ventilation through a body cavity |
| US9486233B2 (en) | 2013-04-26 | 2016-11-08 | Iogyn, Inc. | Tissue resecting systems and methods |
| WO2014178438A1 (ja) * | 2013-05-02 | 2014-11-06 | Saeki Masanori | 毛髪再生用の細胞製剤 |
| US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
| SG11201510177WA (en) | 2013-06-11 | 2016-01-28 | Harvard College | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
| US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
| MX2016001247A (es) | 2013-07-30 | 2016-08-17 | Musculoskeletal Transplant Foundation | Matrices derivadas de tejido suave acelular y metodos para preparar las mismas. |
| ITMO20130227A1 (it) * | 2013-08-02 | 2015-02-03 | Biomed Device Srl | Metodo e sistema per aliquotare grasso da liposuzione |
| WO2015035221A1 (en) | 2013-09-05 | 2015-03-12 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
| CN105764436B (zh) | 2013-09-06 | 2019-04-26 | 普罗赛普特生物机器人公司 | 利用致脱脉冲的用于消融组织的装置 |
| DK3046417T3 (en) | 2013-09-19 | 2017-10-09 | Cytori Therapeutics Inc | PROCEDURES FOR USING Oily Tissue Drained Cells To Treat RAYNAUD'S SYNDROME CONNECTED WITH SCLERODERMIA |
| US9248384B2 (en) | 2013-10-02 | 2016-02-02 | Allergan, Inc. | Fat processing system |
| US9943639B2 (en) | 2013-10-28 | 2018-04-17 | Boston Scientific Scimed, Inc. | Fluid management system and methods |
| BR102013033827B1 (pt) * | 2013-12-27 | 2021-09-08 | Regenera - Medicina Veterinária Avançada Ltda. | Concentrado multipotente e imunocompatível de células-tronco e biofármaco e forma de dosagem que o compreendem |
| CA2938268A1 (en) * | 2014-01-31 | 2015-08-06 | Dsm Ip Assets B.V. | Adipose tissue processing centrifuge and methods of use |
| WO2015167768A1 (en) | 2014-05-02 | 2015-11-05 | Lifecell Corporation | Injection sensor with feedback mechanism |
| US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
| US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
| US10006006B2 (en) | 2014-05-16 | 2018-06-26 | Janssen Biotech, Inc. | Use of small molecules to enhance MAFA expression in pancreatic endocrine cells |
| EP3659638B1 (en) | 2014-07-31 | 2026-01-07 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
| US12133789B2 (en) | 2014-07-31 | 2024-11-05 | Smith & Nephew, Inc. | Reduced pressure therapy apparatus construction and control |
| USD748462S1 (en) | 2014-08-11 | 2016-02-02 | Auxocell Laboratories, Inc. | Centrifuge clip |
| US9993748B2 (en) | 2014-08-11 | 2018-06-12 | Auxocell Laboratories, Inc. | Centrifuge clip and method |
| CA2959342A1 (en) | 2014-08-25 | 2016-03-03 | Reviticell Holdings, Llc | Modular single-use kits and methods for preparation of biological material |
| BR112017004454B1 (pt) * | 2014-09-05 | 2022-11-01 | Procept Biorobotics Corporation | Aparelho para remover células intactas de uma área cirúrgica de um paciente |
| TW201627498A (zh) * | 2015-01-26 | 2016-08-01 | 國立中央大學 | 用於純化及培養幹細胞的孔洞結構及其製造方法、幹細胞純化裝置及使用其的幹細胞純化方法、以及幹細胞培養裝置及使用其的幹細胞培養方法 |
| AU2016229013B2 (en) | 2015-03-10 | 2020-05-21 | Allergan Sales, Llc | Multiple needle injector |
| US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| CA2984874A1 (en) * | 2015-05-05 | 2016-11-10 | Samer Srouji | A fat-depleted adipose tissue and a device and method for preparing the same |
| US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| CA3177726A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| US20160355777A1 (en) | 2015-06-05 | 2016-12-08 | Novartis Ag | Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| JP7057557B2 (ja) * | 2015-07-31 | 2022-04-20 | 国立大学法人大阪大学 | 上皮疾患に対する治療及び／又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤 |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| US10188777B2 (en) | 2015-08-20 | 2019-01-29 | Aurastem Llc | Liposuction device and system and use thereof |
| AU2016342012A1 (en) | 2015-10-21 | 2018-05-10 | Lifecell Corporation | Systems and methods for medical device control |
| CN108350424A (zh) | 2015-10-21 | 2018-07-31 | 生命细胞公司 | 用于管件管理的系统和方法 |
| EP3381458B1 (en) * | 2015-11-24 | 2023-06-07 | Rohto Pharmaceutical Co., Ltd. | Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same |
| US10729827B2 (en) | 2015-12-22 | 2020-08-04 | Lifecell Corporation | Syringe filling device for fat transfer |
| US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
| US11139074B2 (en) | 2016-03-14 | 2021-10-05 | Fenwal, Inc. | Cell washing system with process parameter control |
| KR101733564B1 (ko) * | 2016-03-15 | 2017-05-10 | 경북대학교병원 | 디케토피페라진을 유효성분으로 포함하는 전신염증질환의 예방 또는 치료용 약학적 조성물 |
| EP3872164B1 (en) | 2016-03-17 | 2023-10-04 | Synova Life Sciences, Inc. | Isolating stem cells from adipose tissue |
| RU2725968C2 (ru) | 2016-04-08 | 2020-07-07 | Аллерган, Инк. | Аспирационно-инъекционное устройство |
| DK3443073T3 (da) | 2016-04-14 | 2024-09-02 | Janssen Biotech Inc | Differentiering af pluripotente stamceller til intestinale mellemtarmendodermceller |
| US10449283B2 (en) * | 2016-04-29 | 2019-10-22 | Fenwal, Inc. | System and method for selecting and culturing cells |
| CN105955743B (zh) | 2016-04-29 | 2019-08-27 | 腾讯科技（深圳）有限公司 | 资源数值转移请求生成的方法、装置和系统 |
| US10251990B2 (en) | 2016-04-29 | 2019-04-09 | Fenwal, Inc. | System and method for processing, incubating, and/or selecting biological cells |
| US10702629B2 (en) * | 2016-05-13 | 2020-07-07 | Black Tie Medical Inc. | Conditioning harvested fat for re-injection |
| US11191879B2 (en) | 2016-05-27 | 2021-12-07 | Fenwal, Inc. | Cell processing system and method with preliminary process evaluation |
| KR102802007B1 (ko) | 2016-06-08 | 2025-04-28 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 조직 및 세포를 프로세싱하기 위한 방법 및 장치 |
| US10654000B2 (en) | 2016-07-13 | 2020-05-19 | Fenwal, Inc. | Cell processing system and method with centralized data management, monitoring and/or control |
| DE102016114043B3 (de) * | 2016-07-29 | 2017-08-10 | Technische Universität Dresden | Vorrichtung zur Isolierung von Stammzellen aus fötalen Geweben |
| BR112019003871A2 (pt) | 2016-08-30 | 2019-07-16 | Lifecell Corp | sistemas e métodos para controle de dispositivo médico |
| WO2018084882A1 (en) | 2016-11-02 | 2018-05-11 | The Cooper Health System | Method and apparatus for delivery of cell therapies |
| EP3338823B1 (en) | 2016-12-21 | 2021-06-16 | Fenwal, Inc. | System and method for separating cells incorporating magnetic separation |
| US20180207331A1 (en) * | 2017-01-20 | 2018-07-26 | Puregraft Llc | Chamber for the collection of lipoaspirate |
| US11969459B2 (en) | 2017-01-27 | 2024-04-30 | StemRIM Inc. | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| USD851777S1 (en) | 2017-01-30 | 2019-06-18 | Lifecell Corporation | Canister-type device for tissue processing |
| EP3607046A4 (en) | 2017-04-07 | 2020-05-27 | Epibone, Inc. | SOWING AND CROP SYSTEM AND METHOD |
| WO2018195101A1 (en) | 2017-04-19 | 2018-10-25 | Smith & Nephew, Inc. | Negative pressure wound therapy canisters |
| AU2017410927B2 (en) | 2017-04-28 | 2024-01-11 | Aurastem Llc | Micro-lipo needle devices and use thereof |
| PL3634201T3 (pl) | 2017-06-06 | 2023-09-04 | Thoracent, Inc. | Urządzenie do wykonywania bronchoskopii |
| US11732233B2 (en) | 2017-07-18 | 2023-08-22 | Gid Bio, Inc. | Adipose tissue digestion system and tissue processing method |
| CN119033819A (zh) | 2017-11-22 | 2024-11-29 | 迈索布拉斯特国际有限公司 | 细胞组合物及治疗方法 |
| WO2019107530A1 (ja) | 2017-12-01 | 2019-06-06 | 株式会社ステムリム | 炎症性腸疾患の治療薬 |
| CA3084013A1 (en) | 2017-12-01 | 2019-06-06 | StemRIM Inc. | Ectodermal mesenchymal stem cells and method for producing same |
| GB201720405D0 (en) | 2017-12-07 | 2018-01-24 | Biosafe Sa | A bioprocessing system |
| WO2019156137A1 (ja) | 2018-02-08 | 2019-08-15 | 株式会社ステムリム | 乾癬の治療薬 |
| CN111542350B (zh) * | 2018-04-02 | 2022-10-18 | 联合技术实验室公司 | 用于制备脂肪来源干细胞的系统和方法 |
| CN108676702B (zh) * | 2018-05-23 | 2021-10-15 | 上海蓓蕊医疗科技有限公司 | 一种提取装置及其操作方法 |
| JP6999196B2 (ja) | 2018-07-04 | 2022-01-18 | 正典 佐伯 | 幹細胞濾液製剤及びその調製方法 |
| WO2020051541A1 (en) | 2018-09-07 | 2020-03-12 | Duke University | Nanoparticulate drug delivery systems |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| US11674131B2 (en) | 2018-12-03 | 2023-06-13 | Ross Ward | Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof |
| WO2020174005A1 (en) | 2019-02-28 | 2020-09-03 | The Regenerative Group Ltd. | Regenerative combination of plasma and adipose tissue |
| US20200325436A1 (en) * | 2019-04-10 | 2020-10-15 | Advanced Solutions Life Sciences, Llc | Systems and Methods For Isolating Microvessels From Adipose Tissue |
| US11234684B2 (en) * | 2019-04-19 | 2022-02-01 | Transmed7, Llc | Devices and methods for portable, adjunctive vacuum source and cytology/histology collection systems for biopsy devices |
| RU195366U1 (ru) * | 2019-05-08 | 2020-01-23 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр реабилитации и курортологии" Министерства здравоохранения Российской Федерации (ФГБУ НМИЦ РК Минздрава России) | Устройство для выделения из жировой ткани клеток стромально-васкулярной фракции для последующего их применения в регенеративной медицине |
| EP4386081A3 (en) | 2019-05-21 | 2024-10-16 | President and Fellows of Harvard College | Endocrine differentiation-inducing molecule |
| WO2020263858A1 (en) * | 2019-06-24 | 2020-12-30 | The Regents Of The University Of California | Integrated system for mechanical processing of lipoaspirate |
| AU2020306056B2 (en) | 2019-06-27 | 2022-11-24 | Boston Scientific Scimed, Inc. | Detection of an endoscope to a fluid management system |
| EP3770600B1 (en) * | 2019-07-25 | 2023-05-10 | CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement | Purification process for cells |
| WO2021046001A1 (en) | 2019-09-02 | 2021-03-11 | Stemplant Llc | Method and apparatus for delivery of cell therapies |
| GB201914283D0 (en) | 2019-10-03 | 2019-11-20 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
| US11272996B2 (en) | 2019-10-04 | 2022-03-15 | Reviticell Holdings, Inc. | Methods and devices for performing sequential procedures utilizing a standardized system |
| JP7462043B2 (ja) * | 2019-11-22 | 2024-04-04 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 凝集体を含む液体を移送する装置、システム、および方法 |
| WO2021123832A1 (en) * | 2019-12-20 | 2021-06-24 | Instil Bio (Uk) Limited | Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof |
| KR20220144369A (ko) * | 2020-02-18 | 2022-10-26 | 아피스 메디컬 코퍼레이션 | 의료 절차 중 지방과 근육 조직을 감지하고 식별하기 위한 장치, 시스템 및 방법 |
| GB2587257B (en) * | 2020-03-09 | 2021-09-15 | Alma Lasers Ltd | Lipoaspirate processing |
| KR20230002416A (ko) * | 2020-03-27 | 2023-01-05 | 마이크론브레인 메디컬 씨오., 엘티디. | 생물학적 샘플에서 미생물을 농축 및 검출하기 위한 방법 및 장치 |
| WO2021214162A1 (en) | 2020-04-22 | 2021-10-28 | Cellunite Gmbh | Modular cell processing |
| US20230167398A1 (en) * | 2020-04-22 | 2023-06-01 | Cellunite Gmbh | System and method for automated cell processing |
| WO2021220057A2 (en) * | 2020-04-30 | 2021-11-04 | Scicotec Gmbh | Automated integrated liposuction and tissue processing device and method |
| CN111557952A (zh) * | 2020-05-28 | 2020-08-21 | 澳门大学 | 间充质干细胞在制备用于促进脂肪移植的制剂中的应用 |
| KR20230029764A (ko) * | 2020-06-05 | 2023-03-03 | 듀크 유니버시티 | 자가 지방 이식편을 증강하기 위한 조성물 및 방법 |
| KR102463245B1 (ko) * | 2020-06-19 | 2022-11-07 | 동국대학교 산학협력단 | Mettl7a 과발현 줄기세포를 포함하는 골재생용 조성물, 이를 제조하는 방법 및 이를 포함하는 세포치료제 |
| CA3176245A1 (en) * | 2020-09-14 | 2022-03-17 | Ginkgo Bioworks, Inc. | Use of bone morphogenetic proteins and their receptors for aesthetics and cosmetics |
| EP4213863A4 (en) * | 2020-09-15 | 2025-02-26 | The Brigham and Women's Hospital, Inc. | In vivo adipose bioreactor and kits for the production and delivery of biologic agents |
| EP4259170A4 (en) * | 2020-12-11 | 2024-10-23 | Cytori Therapeutics K.K. | PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION AND TREATMENT OF LIVER FIBROSIS AND/OR LIVER CIRRHOSIS WITH REGENERATIVE CELLS FROM ADIET TISSUE |
| CN115161182A (zh) * | 2021-04-06 | 2022-10-11 | 成都导胜生物技术有限公司 | 一种脂肪细胞消融系统及消融方法 |
| CN117529550A (zh) | 2021-04-11 | 2024-02-06 | 哈佛学院校长同事会 | 心肌细胞和组合物以及用于生产它们的方法 |
| US11679198B2 (en) | 2021-04-28 | 2023-06-20 | Chopra Gryskiewicz, LLC | System and related methods for fat harvesting |
| US20250084362A1 (en) | 2021-07-23 | 2025-03-13 | Cellunite Gmbh | System and method for cell processing |
| CN113976339A (zh) * | 2021-10-25 | 2022-01-28 | 安然 | 改进式脂肪移植装置 |
| JP2024029563A (ja) * | 2022-08-22 | 2024-03-06 | キヤノンメディカルシステムズ株式会社 | 医用情報処理装置、医用情報処理方法及びプログラム |
| EP4704933A1 (en) | 2023-05-03 | 2026-03-11 | Volumina Medical SA | Devices and methods for preparing and conditioning biological assemblies for minimally invasive delivery for tissue engineering, cell therapies and other therapeutic applications |
| US12409264B2 (en) * | 2023-10-16 | 2025-09-09 | Mark Louis Venturi | Adipose tissue separation device with pressure equalization |
| ES3023107A1 (es) * | 2023-11-29 | 2025-05-29 | Herrera Fernando Godoy | Dispositivo de purificación y aislamiento de componentes de un tejido adiposo |
Family Cites Families (210)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4000275A (en) * | 1969-11-24 | 1976-12-28 | Eli Lilly And Company | Immunosuppressants |
| US6436135B1 (en) * | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
| US4346703A (en) | 1979-01-23 | 1982-08-31 | Baxter Travenol Laboratories, Inc. | Solution container for continuous ambulatory peritoneal dialysis |
| US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
| US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
| IT1212892B (it) | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
| JPS5990649A (ja) | 1982-11-12 | 1984-05-25 | Hitachi Koki Co Ltd | 無菌式連続遠心分離システム |
| JPS5990649U (ja) | 1982-12-10 | 1984-06-19 | トヨタ自動車株式会社 | オ−トマチツク車の変速位置表示装置 |
| US5034135A (en) | 1982-12-13 | 1991-07-23 | William F. McLaughlin | Blood fractionation system and method |
| US4699788A (en) | 1984-08-20 | 1987-10-13 | Trustees Of Boston University | Angiogenic factor methods of extraction and method for producing angiogenesis |
| JPH022884Y2 (https=) | 1984-12-25 | 1990-01-24 | ||
| US4820626A (en) | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
| US5312380A (en) * | 1985-06-06 | 1994-05-17 | Thomas Jefferson University | Endothelial cell procurement and deposition kit |
| US5035708A (en) | 1985-06-06 | 1991-07-30 | Thomas Jefferson University | Endothelial cell procurement and deposition kit |
| US5372945A (en) * | 1985-06-06 | 1994-12-13 | Alchas; Paul G. | Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product |
| US4734269A (en) | 1985-06-11 | 1988-03-29 | American Hospital Supply Corporation | Venous reservoir bag with integral high-efficiency bubble removal system |
| US5436135A (en) | 1985-09-02 | 1995-07-25 | Pasteur Merieux Serums Et Vaccins | New preparation of placenta collagen, their extraction method and their applications |
| EP0244447A1 (en) | 1985-10-25 | 1987-11-11 | ATTIKIOUZEL, Yianni | Warning system for rear end vehicle collisions |
| US4990333A (en) | 1985-12-20 | 1991-02-05 | Angio Medical Corporation | Method for healing bone damage |
| ES2004281A6 (es) | 1986-04-04 | 1988-12-16 | Univ Jefferson | Una superficie protesica implantable para implantacion en un paciente humano |
| US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US5079160A (en) * | 1987-06-08 | 1992-01-07 | Lacy Paul E | Method to isolate clusters of cell subtypes from organs |
| US5158867A (en) * | 1987-08-21 | 1992-10-27 | Cryolife Inc. | Method for cryopreserving blood vessels |
| US4883755A (en) * | 1987-10-28 | 1989-11-28 | Thomas Jefferson University | Method of reendothelializing vascular linings |
| US4834703A (en) * | 1987-11-23 | 1989-05-30 | Dubrul Will R | Liposuction filter and lipoplasty device |
| JPH01141583A (ja) | 1987-11-27 | 1989-06-02 | Shimadzu Corp | 細胞処理チャンバ |
| US5143063A (en) * | 1988-02-09 | 1992-09-01 | Fellner Donald G | Method of removing adipose tissue from the body |
| JP2564611B2 (ja) | 1988-06-13 | 1996-12-18 | 株式会社日立製作所 | 生物細胞用遠心分離装置及び細胞の分離方法 |
| US4897185A (en) * | 1988-10-06 | 1990-01-30 | Cobe Laboratories, Inc. | Cell processing apparatus and method |
| US5092883A (en) * | 1988-12-28 | 1992-03-03 | Eppley Barry L | Method for promoting soft connective tissue growth and repair in mammals |
| US5087244A (en) | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
| JPH0666B2 (ja) | 1989-05-02 | 1994-01-05 | 倉敷紡績株式会社 | Ｄｎａの単離精製法 |
| US5521087A (en) | 1989-05-10 | 1996-05-28 | Massachusetts Institute Of Technology | Method for producing oriented connective tissue cells in a ligament configuration |
| EP0418979A3 (en) | 1989-09-21 | 1992-03-04 | Michele Dr. Zocchi | Method and apparatus for producing human autologous collagen |
| DE69018246T2 (de) | 1990-02-09 | 1995-11-02 | Becton Dickinson Co | Vorrichtung zur Sammlung und Verarbeitung von fetten Geweben zur Herstellung von Endothel-Zellprodukt. |
| EP0448770A1 (en) | 1990-03-28 | 1991-10-02 | Katsuya Takasu | Method for separating collagen |
| US5641622A (en) * | 1990-09-13 | 1997-06-24 | Baxter International Inc. | Continuous centrifugation process for the separation of biological components from heterogeneous cell populations |
| JPH0675497B2 (ja) | 1990-11-15 | 1994-09-28 | 倉敷紡績株式会社 | プラスミド分離装置 |
| US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5837539A (en) * | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5811094A (en) * | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
| US6197325B1 (en) * | 1990-11-27 | 2001-03-06 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| US5234608A (en) | 1990-12-11 | 1993-08-10 | Baxter International Inc. | Systems and methods for processing cellular rich suspensions |
| JP2637297B2 (ja) | 1991-02-22 | 1997-08-06 | 帝人株式会社 | 遠心分離装置 |
| NZ242533A (en) | 1991-05-03 | 1995-05-26 | Becton Dickinson Co | Device for collecting and processing fat tissue; vessel with rinsing and digesting chamber, drain chamber and isolation chamber |
| JPH0611309B2 (ja) | 1991-05-28 | 1994-02-16 | 克弥 高須 | コラーゲン採取装置 |
| US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| US5261612A (en) * | 1991-10-09 | 1993-11-16 | Newman-Ftaiha, Inc. | Method and apparatus for extracting injectable collagen from adipose tissue |
| EP0563364A4 (en) | 1991-10-18 | 1994-08-17 | Baxter Int | Bone marrow kit |
| US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| AU665813B2 (en) | 1992-05-11 | 1996-01-18 | Sulzer Medizinaltechnik Ag | Process and apparatus for producing endoprostheses |
| WO1994000484A1 (en) | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
| WO1994002156A1 (en) | 1992-07-16 | 1994-02-03 | The Board Of Trustees Of Leland Stanford Junior University | Methods for using dendritic cells to activate t cells |
| US5336178A (en) | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
| US5654186A (en) * | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
| US5328459A (en) * | 1993-05-06 | 1994-07-12 | Laghi Aldo A | Apparatus and method for dispensing and aspirating high viscosity materials |
| WO1994027698A2 (en) * | 1993-05-28 | 1994-12-08 | Baxter International Inc. | Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations |
| US5316942A (en) * | 1993-06-16 | 1994-05-31 | Battelle Memorial Institute | Process for the production of low-cost soluble high-molecular weight collagen |
| US5409833A (en) * | 1993-07-01 | 1995-04-25 | Baxter International Inc. | Microvessel cell isolation apparatus |
| US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
| US5470307A (en) * | 1994-03-16 | 1995-11-28 | Lindall; Arnold W. | Catheter system for controllably releasing a therapeutic agent at a remote tissue site |
| JPH07255469A (ja) | 1994-03-17 | 1995-10-09 | Kurabo Ind Ltd | 動物細胞の凍結保存液 |
| US5599335A (en) | 1994-03-29 | 1997-02-04 | The Procter & Gamble Company | Absorbent members for body fluids having good wet integrity and relatively high concentrations of hydrogel-forming absorbent polymer |
| US5811050A (en) * | 1994-06-06 | 1998-09-22 | Gabower; John F. | Electromagnetic interference shield for electronic devices |
| US5968753A (en) | 1994-06-14 | 1999-10-19 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
| JP3687975B2 (ja) * | 1994-07-01 | 2005-08-24 | エドワーズ ライフサイエンシーズ コーポレイション | 自己由来の微小血管内皮細胞を含む脂肪組織を採取する方法 |
| US5837235A (en) * | 1994-07-08 | 1998-11-17 | Sulzer Medizinaltechnik Ag | Process for regenerating bone and cartilage |
| FR2723315B1 (fr) * | 1994-08-02 | 1996-10-25 | Cird Galderma | Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes |
| DE4439480C1 (de) | 1994-11-08 | 1996-06-05 | Asta Medica Ag | Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate |
| US5688531A (en) * | 1994-12-23 | 1997-11-18 | Ramot University Authority For Applied Research And Industrial Development, Ltd. | Method for regulating bone forming cells |
| US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
| US5783408A (en) * | 1995-06-07 | 1998-07-21 | Hamilton; Bradford S. | Method for screening potential anti-obesity agents |
| US5888409A (en) * | 1995-06-07 | 1999-03-30 | Cedars-Sinai Medical Center | Methods for cell isolation and collection |
| US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
| US5653689A (en) | 1995-09-30 | 1997-08-05 | Abacus Design & Development, Inc. | Infusion catheter |
| JP3781433B2 (ja) | 1995-11-16 | 2006-05-31 | ケース ウエスターン リザーブ ユニバーシティ | ヒト間葉幹細胞の試験管内軟骨形成誘導 |
| US6200606B1 (en) * | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| EP0877795A4 (en) | 1996-01-16 | 2003-03-05 | Depuy Orthopaedics Inc | INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE |
| US6206873B1 (en) * | 1996-02-13 | 2001-03-27 | El. En. S.P.A. | Device and method for eliminating adipose layers by means of laser energy |
| JP4609807B2 (ja) | 1996-03-28 | 2011-01-12 | 雪印乳業株式会社 | 骨強化用医薬、飲食品及び飼料 |
| JP3322595B2 (ja) * | 1996-03-28 | 2002-09-09 | テルモ株式会社 | フィルター装置および生体微細組織の分離・回収方法 |
| AU2730497A (en) | 1996-04-17 | 1997-11-07 | Case Western Reserve University | Cryopreservation and extensive subculturing of human mesenchymal stem cells |
| US5830714A (en) | 1996-04-17 | 1998-11-03 | Molecular Biology Resources, Inc. | Biologically active fragment of bacillus stearothermophilus DNA polymerase |
| ES2329953T3 (es) | 1996-04-19 | 2009-12-02 | Osiris Therapeutics, Inc. | Regeneracion e incremento de hueso utilizando celulas madre mesenquimales. |
| AU2808397A (en) | 1996-04-26 | 1997-11-19 | Case Western Reserve University | Skin regeneration using mesenchymal stem cells |
| US6020196A (en) * | 1996-05-09 | 2000-02-01 | Baxter International Inc. | Devices for harvesting and homogenizing adipose tissue containing autologous endothelial cells |
| US5785965A (en) | 1996-05-15 | 1998-07-28 | The Board Of Trustees Of The Leland Stanford Junior Univ. | VEGF gene transfer into endothelial cells for vascular prosthesis |
| US5869037A (en) * | 1996-06-26 | 1999-02-09 | Cornell Research Foundation, Inc. | Adenoviral-mediated gene transfer to adipocytes |
| US5727740A (en) * | 1996-07-03 | 1998-03-17 | Robinson; Forrest L. | Method and apparatus for recovering fractional components of soil |
| JPH1017310A (ja) | 1996-07-03 | 1998-01-20 | Ehime Pref Gov | コラーゲン、ヒドロキシアパタイトの製造方法及びその生成物 |
| US6368356B1 (en) * | 1996-07-11 | 2002-04-09 | Scimed Life Systems, Inc. | Medical devices comprising hydrogel polymers having improved mechanical properties |
| US5837444A (en) * | 1996-07-16 | 1998-11-17 | Shah; Kumarpal A. | Islet cell transplantation machine for diabetes cure |
| US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
| US5980887A (en) * | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
| CA2271758A1 (en) | 1996-11-15 | 1998-05-22 | Osiris Therapeutics, Inc. | Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes |
| ATE272109T1 (de) | 1996-11-19 | 2004-08-15 | Roche Diagnostics Gmbh | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden |
| US5728740A (en) * | 1996-12-05 | 1998-03-17 | Barrett; Mark William | Method and composition for treating bacterial infections in plants |
| DE69734395T2 (de) | 1996-12-06 | 2006-07-27 | Osiris Therapeutics, Inc. | Verbesserte chondrogene differenzierung von menschlichen mesenchym-stammzellen |
| US5830741A (en) | 1996-12-06 | 1998-11-03 | Boehringer Mannheim Corporation | Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease |
| CA2278208C (en) * | 1997-01-24 | 2011-09-20 | Asahi Medical Co., Ltd. | Cell separation method |
| WO1998035659A1 (en) | 1997-02-18 | 1998-08-20 | Lxr Biotechnology Inc. | Bak promotor expression system |
| US7767452B2 (en) * | 1997-02-20 | 2010-08-03 | Kleinsek Don A | Tissue treatments with adipocyte cells |
| US6086582A (en) * | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
| AU7481098A (en) | 1997-05-13 | 1998-12-08 | Case Western Reserve University | Osteoarthritis cartilage regeneration using human mesenchymal stem ce lls |
| WO1998052629A2 (en) | 1997-05-20 | 1998-11-26 | Zymequest, Inc. | Cell processing systems |
| US5786207A (en) | 1997-05-28 | 1998-07-28 | University Of Pittsburgh | Tissue dissociating system and method |
| US5817050A (en) * | 1997-05-29 | 1998-10-06 | Klein; Jeffrey A. | Liposuction cannula |
| US6451207B1 (en) | 1997-06-04 | 2002-09-17 | Dexter Magnetic Technologies, Inc. | Magnetic cell separation device |
| JPH114682A (ja) | 1997-06-16 | 1999-01-12 | Asahi Medical Co Ltd | 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法 |
| CA2294944A1 (en) | 1997-07-03 | 1999-01-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
| CA2296704C (en) * | 1997-07-14 | 2010-10-19 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| JPH1157731A (ja) | 1997-08-15 | 1999-03-02 | Japan Organo Co Ltd | 浄水処理方法および浄水処理設備 |
| US6043066A (en) | 1997-09-04 | 2000-03-28 | Mangano; Joseph A. | Cell separation using electric fields |
| US6077987A (en) | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
| CA2312847C (en) | 1997-12-02 | 2014-09-30 | Zen Bio, Inc. | Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| AU749358B2 (en) | 1998-01-23 | 2002-06-27 | Pall Corporation | Biological fluid treatment system |
| AU749675B2 (en) | 1998-03-13 | 2002-07-04 | Mesoblast International Sarl | Uses for human non-autologous mesenchymal stem cells |
| US6206914B1 (en) * | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
| AU4336599A (en) * | 1998-06-08 | 1999-12-30 | Osiris Therapeutics, Inc. | (in vitro) maintenance of hematopoietic stem cells |
| US6001642A (en) | 1998-06-29 | 1999-12-14 | Wyle Laboratories, Inc. Life Sciences | Bioreactor and cell culturing processes using the bioreactor |
| DE19841835C2 (de) | 1998-09-12 | 2003-05-28 | Fresenius Ag | Zentrifugenkammer für einen Zellseparator |
| AU767241B2 (en) * | 1998-09-14 | 2003-11-06 | Qiang Xu | Immunosuppressive agents |
| US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
| US6090121A (en) * | 1998-12-02 | 2000-07-18 | Weber; Paul J. | Highly flexible, reinforced swan neck liposuction cannulas |
| US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
| US20030082152A1 (en) * | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
| BR0008552A (pt) * | 1999-03-10 | 2002-05-07 | Univ Pittsburgh | Células tronco e redes derivadas de tecido adiposo |
| JP4195250B2 (ja) | 1999-03-12 | 2008-12-10 | 株式会社神鋼環境ソリューション | ビール等の発酵食品類の製造方法 |
| JP4014350B2 (ja) | 1999-03-12 | 2007-11-28 | 株式会社神鋼環境ソリューション | 酵母液貯留用攪拌槽と、その攪拌槽を用いたビール等の発酵食品類の製造方法、並びにその攪拌槽に具備された攪拌翼 |
| US6764820B2 (en) | 1999-03-26 | 2004-07-20 | Ludwig Institute For Cancer Research | Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) |
| US20030211085A1 (en) * | 2000-03-16 | 2003-11-13 | Sanberg Paul R. | Cell therapy for chronic stroke |
| US6316247B1 (en) | 1999-06-15 | 2001-11-13 | University Of Pittsburgh | System and method for refining liposuctioned adipose tissue |
| US6804558B2 (en) * | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
| US6555374B1 (en) * | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| US6429013B1 (en) * | 1999-08-19 | 2002-08-06 | Artecel Science, Inc. | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| CN1134537C (zh) * | 1999-09-08 | 2004-01-14 | 何清华 | 人原始间叶干细胞群的制备方法 |
| EP1218489B1 (en) | 1999-09-24 | 2009-03-18 | Cybios LLC | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| US20030161817A1 (en) * | 2001-03-28 | 2003-08-28 | Young Henry E. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| JP3524835B2 (ja) | 2000-02-25 | 2004-05-10 | 財団法人地球環境産業技術研究機構 | 光合成培養装置及び培養方法 |
| ES2300320T3 (es) | 2000-02-26 | 2008-06-16 | Artecel, Inc. | Celulas madre pluripotentes generadas a partir de celulas del estroma derivadas de tejido adiposo y sus usos. |
| US20070111935A1 (en) | 2000-04-06 | 2007-05-17 | Franco Wayne P | Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| ATE328067T1 (de) * | 2000-04-28 | 2006-06-15 | Childrens Medical Center | Isolierung von mesenchymalen stammzellen und deren verwendung |
| AU2001264565B2 (en) | 2000-05-03 | 2006-12-07 | Vegenics Limited | A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof |
| CA2408701A1 (en) * | 2000-05-12 | 2001-11-22 | University Of Utah Research Foundation | Compositions and methods for tissue dedifferentiation and regeneration |
| US20040172283A1 (en) | 2003-02-09 | 2004-09-02 | Vanderveen Timothy W. | Medication management and event logger and analysis system |
| US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
| MXPA03002414A (es) * | 2000-09-18 | 2004-07-08 | Organogenesis Inc | Protesis con injerto de hoja plana tratada por bioingenieria y su uso. |
| JP4141122B2 (ja) * | 2000-11-06 | 2008-08-27 | サカセ・アドテック株式会社 | インフレータブル構造及びインフレータブル構造を備えたアレーアンテナ及びインフレータブル構造の展開方法 |
| US6576464B2 (en) * | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
| US7192445B2 (en) * | 2000-12-06 | 2007-03-20 | Astra Tech Ab | Medical prosthetic devices and implants having improved biocompatibility |
| US6517526B1 (en) | 2000-12-29 | 2003-02-11 | Yehuda Tamari | Container for lyophilizing biological products |
| FR2819265B1 (fr) | 2001-01-10 | 2004-01-02 | Centre Nat Rech Scient | Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques |
| EP1361896A2 (en) | 2001-01-23 | 2003-11-19 | Boston Scientific Corporation | Localized myocardial injection method for treating ischemic myocardium |
| US6723131B2 (en) | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
| EP1379869A4 (en) | 2001-03-15 | 2004-08-11 | Xiao Yong Fu | METHOD FOR THERAPEUTICALLY TREATING A CLINICALLY DETECTED CARDIOPATHOLOGICAL FORM IN A MAMMAL |
| JP2004536794A (ja) | 2001-04-09 | 2004-12-09 | メドトロニック、インコーポレイテッド | マイクロ遠心機を用いる血液成分の分離方法及びその使用法 |
| US6623959B2 (en) * | 2001-06-13 | 2003-09-23 | Ethicon, Inc. | Devices and methods for cell harvesting |
| AU2002315397A1 (en) | 2001-06-20 | 2003-01-08 | Power Medical Interventions, Inc. | A method and system for integrated medical tracking |
| WO2003002165A1 (en) * | 2001-06-28 | 2003-01-09 | Cook Biotech Incorporated | Graft prosthesis devices containing renal capsule collagen |
| US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
| JP2005508393A (ja) * | 2001-11-09 | 2005-03-31 | アーテセル・サイエンシズ・インコーポレーテツド | 胚および成人幹細胞をサポートするための間質細胞の使用の方法および組成物 |
| RU2331668C2 (ru) | 2001-11-09 | 2008-08-20 | Артесел Сайенсиз, Инк. | Стромальные клетки, полученные из жировой ткани, для заживления дефектов роговицы и внутриглазных дефектов и их использование |
| US6833270B2 (en) * | 2001-11-27 | 2004-12-21 | Biorep Technologies, Inc. | Apparatus and method for isolating cells from organs |
| US7514075B2 (en) * | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
| US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
| US7595043B2 (en) | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| JP4653952B2 (ja) * | 2001-12-07 | 2011-03-16 | サイトリ セラピューティクス インコーポレイテッド | 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法 |
| US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| US20050008626A1 (en) | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
| EP1467746A4 (en) | 2001-12-20 | 2006-10-04 | Macropore Inc | SYSTEMS AND METHODS FOR TREATING PATIENTS WITH COLLAGEN-RICH MATERIAL EXTRACTED FROM ADIPOSE TISSUES |
| US20030161916A1 (en) | 2002-02-26 | 2003-08-28 | Roy Parker | Method for preparing food article |
| WO2003073998A2 (en) | 2002-03-02 | 2003-09-12 | Board Of Regents, The University Of Texas System | Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| AU2003217966A1 (en) | 2002-03-07 | 2003-10-08 | Licentia, Ltd. | Lymphatic and blood endothelial cell genes |
| AU2003220424A1 (en) | 2002-03-19 | 2003-10-08 | Advanced Research And Technology Transfer | Adipose stromal stem cells for tissue and vascular modification |
| JP4603883B2 (ja) | 2002-07-31 | 2010-12-22 | サントル・ナショナル・ドゥ・ラ・レシェルシュ・サイエンティフィーク−セ・エン・エール・エス− | 脂肪組織由来の幹細胞および前記細胞から分化した細胞 |
| US20050271636A1 (en) | 2002-08-09 | 2005-12-08 | St. Jude Children's Research Hospital, Inc. | Diagnostic and therapeutic uses for prox 1 |
| JP2004099471A (ja) | 2002-09-05 | 2004-04-02 | Cardio Corp | 心筋梗塞および心不全の治療薬 |
| US20040136968A1 (en) | 2002-09-27 | 2004-07-15 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
| WO2004052418A1 (ja) | 2002-12-06 | 2004-06-24 | National Institute Of Advanced Industrial Science And Technology | 骨−軟骨組織の再生用移植体 |
| CA2516510C (en) | 2003-02-20 | 2012-07-10 | Macropore Biosurgery, Inc. | Method of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| JP2004272762A (ja) | 2003-03-11 | 2004-09-30 | Topcon Corp | 医療用ネットワークシステム、情報処理装置、課金処理方法、そのためのプログラム、および、このプログラムを記録した情報記録媒体 |
| US20040193274A1 (en) | 2003-03-28 | 2004-09-30 | Trieu Hai H. | Materials and methods for augmenting and/or repairing intervertebral discs |
| US20040197304A1 (en) | 2003-04-01 | 2004-10-07 | The Procter & Gamble Company And Alimentary Health, Ltd. | Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| MXPA05010920A (es) | 2003-05-07 | 2006-06-05 | Aleeva Medical Inc | Tratamiento contra el dolor de espalda, mediante el restablecimiento del intercambio de nutrientes y desechos. |
| KR101127305B1 (ko) | 2003-06-25 | 2012-04-23 | 사이토리 테라퓨틱스, 인크. | 조직으로부터 재생성 세포를 분리하고 농축시키기 위한시스템 및 방법 |
| FR2859381B1 (fr) | 2003-09-05 | 2008-07-25 | Centre Nat Rech Scient | Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel |
| CA2539346A1 (en) | 2003-09-17 | 2005-04-21 | Macropore Biosurgery, Inc. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| US9074190B2 (en) | 2003-10-07 | 2015-07-07 | Biomaster, Inc. | Cell differentiation of adipose-derived precursor cells |
| JP2007508018A (ja) | 2003-10-08 | 2007-04-05 | べト−ステム インコーポレイテッド | 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット |
| KR100821128B1 (ko) | 2003-11-04 | 2008-04-14 | 가부시키가이샤 바이오마스타 | 지방 조직으로부터 줄기세포를 생성하는 방법 및 시스템 |
| JP4336821B2 (ja) | 2003-12-25 | 2009-09-30 | 有限会社金沢大学ティ・エル・オー | 哺乳動物の骨髄細胞または臍帯血由来細胞と脂肪組織を利用した心筋細胞の誘導 |
| WO2005087954A2 (en) | 2004-03-08 | 2005-09-22 | Ludwig Institute For Cancer Research | Roles of foxc2, pdgfr, vegfr3 in lymphatic vessel development |
| EP1765980A4 (en) | 2004-07-02 | 2007-12-12 | Cytori Therapeutics Inc | SYSTEMS AND METHOD FOR THE INSULATION AND USE OF CLINICALLY SAFE, FAT-GUN-GENERATING REGENERATIVE CELLS |
| WO2006028648A2 (en) | 2004-08-13 | 2006-03-16 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Support system for flexible lyophilization containers |
| EP2428563A1 (en) | 2005-02-10 | 2012-03-14 | Regents Of The University Of Minnesota | Vascular/lymphatic endothelial cells |
| KR101278437B1 (ko) | 2005-05-25 | 2013-06-25 | 사이토리 테라퓨틱스, 인크. | 심혈관 증상의 치료에 지방조직-유래의 세포를 사용하는방법 |
| EP1986731A4 (en) | 2006-02-09 | 2012-11-07 | Aderans Res Inst Inc | APPARATUS AND METHODS FOR DELIVERING FLUID AND MATERIAL TO A SUBJECT |
| FR2901136B1 (fr) | 2006-05-18 | 2010-10-01 | Centre Nat Rech Scient | Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral |
| US20100015104A1 (en) | 2006-07-26 | 2010-01-21 | Cytori Therapeutics, Inc | Generation of adipose tissue and adipocytes |
| WO2009076548A1 (en) | 2007-12-13 | 2009-06-18 | Cytori Therapeutics, Inc. | Methods of inhibiting tumor development using adipose-derived regenerative cells |
| WO2010124235A1 (en) | 2009-04-23 | 2010-10-28 | Cytori Therapeutics, Inc. | Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney |
-
2002
- 2002-12-09 JP JP2003554106A patent/JP4653952B2/ja not_active Expired - Lifetime
- 2002-12-09 US US10/316,127 patent/US20030161816A1/en not_active Abandoned
- 2002-12-09 KR KR1020117028207A patent/KR20120003961A/ko not_active Ceased
- 2002-12-09 KR KR1020077018245A patent/KR100930139B1/ko not_active Expired - Fee Related
- 2002-12-09 ES ES07124088.1T patent/ES2545385T3/es not_active Expired - Lifetime
- 2002-12-09 BR BRPI0214772-6A patent/BR0214772A/pt not_active Application Discontinuation
- 2002-12-09 KR KR1020087027860A patent/KR101083454B1/ko not_active Expired - Fee Related
- 2002-12-09 CN CN201010105630.7A patent/CN101897724B/zh not_active Expired - Lifetime
- 2002-12-09 CA CA2469370A patent/CA2469370C/en not_active Expired - Fee Related
- 2002-12-09 EP EP20100183690 patent/EP2305276A3/en not_active Withdrawn
- 2002-12-09 AU AU2002357135A patent/AU2002357135C1/en not_active Ceased
- 2002-12-09 CN CN028279689A patent/CN1630526B/zh not_active Expired - Lifetime
- 2002-12-09 EP EP02805565.5A patent/EP1572071B1/en not_active Expired - Lifetime
- 2002-12-09 CA CA2849201A patent/CA2849201A1/en not_active Abandoned
- 2002-12-09 DK DK07124088.1T patent/DK1921133T3/en active
- 2002-12-09 KR KR1020047008785A patent/KR100811995B1/ko not_active Expired - Fee Related
- 2002-12-09 EP EP20070124088 patent/EP1921133B1/en not_active Expired - Lifetime
- 2002-12-09 WO PCT/US2002/039465 patent/WO2003053346A2/en not_active Ceased
- 2002-12-09 EP EP20100183737 patent/EP2308963A3/en not_active Withdrawn
- 2002-12-09 KR KR1020107002719A patent/KR101150666B1/ko not_active Expired - Fee Related
-
2003
- 2003-07-07 US US10/614,431 patent/US7473420B2/en not_active Expired - Fee Related
- 2003-07-07 US US10/614,643 patent/US7429488B2/en not_active Expired - Lifetime
- 2003-07-07 US US10/614,644 patent/US7390484B2/en not_active Expired - Lifetime
- 2003-07-07 US US10/614,392 patent/US7501115B2/en not_active Expired - Lifetime
- 2003-07-07 US US10/614,648 patent/US8119121B2/en not_active Expired - Fee Related
-
2006
- 2006-10-20 US US11/584,202 patent/US7687059B2/en not_active Expired - Fee Related
-
2010
- 2010-01-06 JP JP2010001420A patent/JP5883553B2/ja not_active Expired - Lifetime
- 2010-09-20 US US12/886,341 patent/US7887795B2/en not_active Expired - Fee Related
- 2010-09-20 US US12/886,353 patent/US7901672B2/en not_active Expired - Fee Related
-
2011
- 2011-03-07 US US13/042,334 patent/US8337834B2/en not_active Expired - Fee Related
-
2012
- 2012-04-12 JP JP2012091080A patent/JP5575174B2/ja not_active Expired - Lifetime
- 2012-12-21 US US13/725,814 patent/US9198937B2/en not_active Expired - Fee Related
-
2013
- 2013-11-22 JP JP2013242179A patent/JP5938029B2/ja not_active Expired - Lifetime
-
2015
- 2015-11-30 US US14/954,584 patent/US20160143952A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2469370C (en) | Adipose-derived cell processing unit | |
| Class et al. | Patent application title: ADIPOSE-DERIVED REGENERATIVE CELLS FOR TREATING LIVER INJURY Inventors: John K. Fraser (San Diego, CA, US) Marc H. Hedrick (Solana Beach, CA, US) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20201209 |